Neurogenic Bladder
Neurogenic bladder is a condition where nerve damage affects the bladder's ability to store or release urine, leading to issues such as incontinence or urinary retention.
Vibegron for Children with Neurogenic Detrusor Overactivity
We are studying the safety and effectiveness of vibegron in children aged 2 to under 18 with neurogenic detrusor overactivity who use clean intermittent catheterization. This trial aims to understand how well the medication works and how it is processed in young patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 2 and 17 years old?
- Do you weigh at least 11 kg if you are between 2 and 12 years old, or at least 29.5 kg if you are between 12 and 17 years old?
- Have you been diagnosed with neurogenic bladder dysfunction (NDO) due to a spinal cord issue or injury at least 6 months ago?
- Are you currently taking digoxin or lithium, or do you plan to start taking either of these medications?
- Are you a female who is currently breastfeeding or planning to breastfeed within 28 days after the study?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitair Ziekenhuis Gent
Urology
Ledeberg, Belgium
Antwerp University Hospital
Urology
Wilrijk, Belgium
KBC Split
Department of Pediatrics
Split, Croatia
Sponsor: Urovant Sciences GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.